Атеросклероз
(Jun 2016)
HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 2. A COMMON APPROACHES FOR STATIN’S USING
A. E. Bagriy,
A. I. Dyadyk,
M. V. Khomenko,
I. N. Tsiba,
V. A. Efremenko,
E. V. Schukina,
O. A. Prikolota
Affiliations
A. E. Bagriy
Donetsk State Medical University Russian Federation
A. I. Dyadyk
Donetsk State Medical University Russian Federation
M. V. Khomenko
Donetsk State Medical University Russian Federation
I. N. Tsiba
Donetsk State Medical University Russian Federation
V. A. Efremenko
Donetsk State Medical University Russian Federation
E. V. Schukina
Donetsk State Medical University Russian Federation
O. A. Prikolota
Donetsk State Medical University Russian Federation
Journal volume & issue
Vol. 12,
no. 2
pp.
48
– 57
Abstract
Read online
This article is devoted to discussion about main aspects of current use of 3-hydroxy-3-methylglutaril CoA reductase inhibitors (statins) according last international guidelines. Statin’s base effects on lipid profile, medication regimens, side effects and safety ensuring are represented.
Keywords
Published in Атеросклероз
ISSN
2078-256X (Print)
2949-3633 (Online)
Publisher
Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
Country of publisher
Russian Federation
LCC subjects
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website
https://ateroskleroz.elpub.ru/jour/index
About the journal
WeChat QR code
Close